Start for free
Start for free
Remeditex Ventures logo

Remeditex Ventures

North America, Texas, United States, Dallas

Description

Remeditex was formed to invest in high quality, innovative, early stage projects that are judged to have commercialization potential.

Investor Profile

Remeditex Ventures has made 17 investments, with 0 in the past 12 months and 29% as lead.

Stage Focus

  • Series B (47%)
  • Series C (24%)
  • Series A (18%)
  • Series D (6%)
  • Post Ipo Equity (6%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Therapeutics
  • Biotechnology
  • Pharmaceutical
  • Medical Device
  • Oncology
  • Genetics
  • Health Diagnostics
  • Life Science
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Remeditex Ventures frequently co-invest with?

Amgen Ventures
Amgen Ventures
North America, California, United States, San Francisco
Co-Investments: 3
Atlas Venture
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 6
Novo Holdings
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 2
Broadview Ventures
Broadview Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 3
F-Prime Capital
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
The Column Group
The Column Group
North America, California, United States, San Francisco
Co-Investments: 2
Brace Pharma
Brace Pharma
North America, Maryland, United States, Rockville
Co-Investments: 2
Vivo Capital
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Presidio Partners
Presidio Partners
North America, California, United States, San Francisco
Co-Investments: 2
Boulder Ventures
Boulder Ventures
North America, Colorado, United States, Boulder
Co-Investments: 5

Which angels does Remeditex Ventures often collaborate with?

James Brown
Shared Deals: 1

What are some of recent deals done by Remeditex Ventures?

Soliton

Houston, Texas, United States

Soliton is developing game-changing science to address multiple multibillion-dollar market opportunities.

Beauty
Post Ipo EquityJun 17, 2019
Amount Raised: $9,450,000
Rodin Therapeutics

Cambridge, Massachusetts, United States

Rodin Therapeutics develops novel therapeutics for neurological disorders by applying insights of epigenetics.

BiotechnologyHealth CareTherapeutics
Series CSep 18, 2017
Amount Raised: $27,000,000
VYNE Therapeutics

Menlo Park, California, United States

VYNE Therapeutics is a clinical late-stage biopharmaceutical company developing treatments associated with dermatologic conditions.

Health CarePharmaceuticalTherapeutics
Series CJul 18, 2017
Amount Raised: $50,500,000
Peloton Therapeutics

Dallas, Texas, United States

Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.

BiotechnologyHealth CareMedical DeviceOncologyPharmaceuticalTherapeutics
Series DSep 15, 2016
Amount Raised: $52,400,000
Navitor Pharmaceuticals

Cambridge, Massachusetts, United States

Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.

BiopharmaBiotechnologyDeveloper PlatformHealth DiagnosticsPharmaceutical
Series BDec 18, 2015
Amount Raised: $33,000,000
Viridian Therapeutics

Waltham, Massachusetts, United States

Viridian Therapeutics is a biotechnology company that offers treatments for patients suffering from diseases.

BiotechnologyGeneticsHealth CareTherapeutics
Series CNov 10, 2015
Amount Raised: $40,700,000
VYNE Therapeutics

Menlo Park, California, United States

VYNE Therapeutics is a clinical late-stage biopharmaceutical company developing treatments associated with dermatologic conditions.

Health CarePharmaceuticalTherapeutics
Series BNov 1, 2015
Amount Raised: $45,000,000
VYNE Therapeutics

Menlo Park, California, United States

VYNE Therapeutics is a clinical late-stage biopharmaceutical company developing treatments associated with dermatologic conditions.

Health CarePharmaceuticalTherapeutics
Series AMay 1, 2015
Amount Raised: $14,300,000
Viridian Therapeutics

Waltham, Massachusetts, United States

Viridian Therapeutics is a biotechnology company that offers treatments for patients suffering from diseases.

BiotechnologyGeneticsHealth CareTherapeutics
Series BFeb 18, 2015
Amount Raised: $8,500,000
Viridian Therapeutics

Waltham, Massachusetts, United States

Viridian Therapeutics is a biotechnology company that offers treatments for patients suffering from diseases.

BiotechnologyGeneticsHealth CareTherapeutics
Series BJun 27, 2014
Amount Raised: $7,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator